Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BILINASDAQ:HQYNASDAQ:MEDPNASDAQ:PAYO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBILIBilibili$19.79+0.3%$18.37$12.72▼$31.77$8.25B0.896.16 million shs28,171 shsHQYHealthEquity$100.83-1.1%$95.99$65.01▼$116.65$8.63B0.49844,861 shs1.22 million shsMEDPMedpace$308.29+1.9%$299.87$250.05▼$459.77$8.73B1.47366,922 shs953,785 shsPAYOPayoneer Global$6.53+0.7%$6.80$5.03▼$11.29$2.35B0.993.20 million shs12,800 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBILIBilibili0.00%-1.40%+4.28%-0.65%+8.82%HQYHealthEquity0.00%-3.30%+2.31%+12.16%+21.11%MEDPMedpace0.00%+3.73%+4.91%-6.42%-23.43%PAYOPayoneer Global0.00%-0.31%-4.70%-17.11%+19.30%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBILIBilibili2.0741 of 5 stars1.55.00.00.02.01.71.9HQYHealthEquity3.2915 of 5 stars3.51.00.00.03.42.51.9MEDPMedpace4.55 of 5 stars3.11.00.04.63.04.21.9PAYOPayoneer Global4.5569 of 5 stars4.55.00.00.02.22.52.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBILIBilibili 2.92Moderate Buy$21.629.25% UpsideHQYHealthEquity 3.00Buy$118.0917.12% UpsideMEDPMedpace 2.23Hold$349.3013.30% UpsidePAYOPayoneer Global 3.00Buy$10.4459.74% UpsideCurrent Analyst Ratings BreakdownLatest PAYO, BILI, HQY, and MEDP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/5/2025HQYHealthEquityBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$112.00 ➝ $125.006/5/2025HQYHealthEquityDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$98.00 ➝ $115.006/4/2025HQYHealthEquityThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$94.00 ➝ $104.006/4/2025HQYHealthEquityRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$112.00 ➝ $117.006/4/2025HQYHealthEquityJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Outperform ➝ Market Outperform$110.00 ➝ $117.006/4/2025HQYHealthEquityBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$110.00 ➝ $125.005/27/2025PAYOPayoneer GlobalJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.00 ➝ $8.505/22/2025HQYHealthEquityRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$105.00 ➝ $112.005/22/2025PAYOPayoneer GlobalCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$13.00 ➝ $10.005/21/2025BILIBilibiliHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/21/2025BILIBilibiliHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$21.50 ➝ $22.50(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBILIBilibili$3.68B2.25$0.45 per share43.69$4.64 per share4.27HQYHealthEquity$1.20B7.27$4.24 per share23.76$24.40 per share4.13MEDPMedpace$2.11B4.20$13.91 per share22.17$26.56 per share11.61PAYOPayoneer Global$977.72M2.42$0.47 per share13.87$2.01 per share3.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBILIBilibili-$184.51M-$0.20N/A43.98N/A-2.15%-2.59%-1.12%8/28/2025 (Estimated)HQYHealthEquity$96.70M$1.3772.8235.501.559.80%11.01%6.77%9/2/2025 (Estimated)MEDPMedpace$404.39M$13.1023.1922.575.5819.31%54.36%20.81%7/28/2025 (Estimated)PAYOPayoneer Global$121.16M$0.3021.6917.66N/A11.32%15.70%1.53%8/6/2025 (Estimated)Latest PAYO, BILI, HQY, and MEDP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/3/2025Q1 2026HQYHealthEquity$0.81$0.97+$0.16$0.61$322.25 million$330.80 million5/7/2025Q1 2025PAYOPayoneer Global$0.07$0.05-$0.02$0.05$244.52 million$246.62 million4/21/2025Q1 2025MEDPMedpace$3.06$3.67+$0.61$3.67$528.38 million$558.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBILIBilibiliN/AN/AN/AN/AN/AHQYHealthEquityN/AN/AN/AN/AN/AMEDPMedpaceN/AN/AN/AN/AN/APAYOPayoneer GlobalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBILIBilibili0.231.361.36HQYHealthEquity0.504.064.06MEDPMedpaceN/A0.730.73PAYOPayoneer GlobalN/A1.001.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBILIBilibili16.08%HQYHealthEquity99.55%MEDPMedpace77.98%PAYOPayoneer Global82.22%Insider OwnershipCompanyInsider OwnershipBILIBilibili22.20%HQYHealthEquity1.50%MEDPMedpace20.30%PAYOPayoneer Global2.58%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBILIBilibili8,088417.99 million325.19 millionOptionableHQYHealthEquity3,12086.47 million85.18 millionOptionableMEDPMedpace5,90028.74 million22.91 millionOptionablePAYOPayoneer Global2,407361.67 million352.34 millionOptionablePAYO, BILI, HQY, and MEDP HeadlinesRecent News About These CompaniesExchange Traded Concepts LLC Invests $741,000 in Payoneer Global Inc. (NASDAQ:PAYO)June 21 at 3:43 AM | marketbeat.comGAMMA Investing LLC Acquires 42,834 Shares of Payoneer Global Inc. (NASDAQ:PAYO)June 21 at 3:18 AM | marketbeat.comTrump's tariffs will lead to erosion of US global payments dominanceJune 20 at 10:30 AM | americanbanker.comPayoneer CEO sees trade bumps as short-termJune 18, 2025 | finance.yahoo.comShort Interest in Payoneer Global Inc. (NASDAQ:PAYO) Decreases By 31.6%June 17, 2025 | marketbeat.comHead-To-Head Review: Payoneer Global (NASDAQ:PAYO) & MoneyOnMobile (OTCMKTS:MOMT)June 16, 2025 | americanbankingnews.comAnalyzing Payoneer Global (NASDAQ:PAYO) & Remitly Global (NASDAQ:RELY)June 13, 2025 | americanbankingnews.comSG Americas Securities LLC Buys 1,164,128 Shares of Payoneer Global Inc. (NASDAQ:PAYO)June 12, 2025 | marketbeat.comFTX Expands Global Payouts with Payoneer as New Distribution PartnerJune 11, 2025 | crypto2community.comFtx Adds Payoneer as Payment Method for CreditorsJune 11, 2025 | coinspeaker.comFTX Partners with Payoneer to Expand Customer Repayment OptionsJune 11, 2025 | livebitcoinnews.comPayoneer Global Announces Partial Adjournment of 2025 Annual Meeting of StockholdersJune 10, 2025 | businesswire.comNorthland Capmk Comments on Payoneer Global Q1 EarningsJune 9, 2025 | marketbeat.comPayoneer Global Inc. (NASDAQ:PAYO) Receives Consensus Rating of "Buy" from BrokeragesJune 9, 2025 | marketbeat.comVietnamese SMEs leverage digitalisation to penetrate global marketJune 8, 2025 | msn.comLucinity Appoints Payoneer CCO and Goldman Sachs MD as Strategic AdvisorsJune 6, 2025 | finance.yahoo.comInsider Selling: Payoneer Global Inc. (NASDAQ:PAYO) Director Sells 16,180 Shares of StockJune 5, 2025 | insidertrades.comPayoneer Global Inc. (NASDAQ:PAYO) Director Sells $109,538.60 in StockJune 4, 2025 | marketbeat.comFintech Firm Payoneer Says China Truce Is Great for Global TradeJune 4, 2025 | msn.comTop 10 Payment ProcessorsJune 3, 2025 | fintechmagazine.comPayoneer Global Inc. (NASDAQ:PAYO) Short Interest Down 20.5% in MayJune 2, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAXON: Competition Intensifies as Motorola Makes $4.4B AcquisitionBy Leo Miller | May 31, 2025View AXON: Competition Intensifies as Motorola Makes $4.4B Acquisition3 High-Paying Dividend Stocks That Still Have Safe PayoutsBy Chris Markoch | May 27, 2025View 3 High-Paying Dividend Stocks That Still Have Safe PayoutsChime’s Smart IPO: Half the Valuation, Double the StrengthBy Jeffrey Neal Johnson | June 18, 2025View Chime’s Smart IPO: Half the Valuation, Double the StrengthIs D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker?By Nathan Reiff | June 16, 2025View Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker?Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock By Jeffrey Neal Johnson | May 28, 2025View Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock PAYO, BILI, HQY, and MEDP Company DescriptionsBilibili NASDAQ:BILI$19.79 +0.05 (+0.26%) As of 09:42 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. It offers a range of digital content, including professional user generated videos, mobile games, and value-added services, such as live broadcasting, occupationally generated videos, audio drama on Maoer, and comics on Bilibili Comic. The company also provides advertising services; and IP derivatives and other services. In addition, it engages in the business and technology development activities; e-commerce business; and video, comics, and game distribution activities. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.HealthEquity NASDAQ:HQY$100.83 -1.17 (-1.15%) As of 09:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.Medpace NASDAQ:MEDP$308.29 +5.60 (+1.85%) As of 09:42 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.Payoneer Global NASDAQ:PAYO$6.53 +0.04 (+0.68%) As of 09:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Payoneer Global Inc. operates as a financial technology company. It operates a payment infrastructure platform that provides customers with a one-stop, global, multi-currency account to serve their accounts receivable and accounts payable needs. The company delivers a suite of services that includes cross-border payments, physical and virtual MasterCard cards, working capital, risk management, and other services. It also offers various payment options with minimal integration required, full back-office functions, and customer support offered. The company's platform delivers bank-grade security, stability, and redundancy. It serves customers, such as small and medium-sized businesses in approximately 190 countries and territories worldwide. Payoneer Global Inc. was founded in 2005 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
